Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency | 3 | 2023 | 138 | 1.180 |
Why?
|
| Acute Kidney Injury | 4 | 2023 | 404 | 0.800 |
Why?
|
| Peritoneal Dialysis | 4 | 2019 | 37 | 0.770 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 182 | 0.720 |
Why?
|
| Kidney Transplantation | 3 | 2020 | 189 | 0.630 |
Why?
|
| Peritonitis | 3 | 2019 | 33 | 0.470 |
Why?
|
| Hypothermia, Induced | 2 | 2023 | 48 | 0.410 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2023 | 70 | 0.390 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 286 | 0.350 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 321 | 0.340 |
Why?
|
| Hyperuricemia | 1 | 2007 | 7 | 0.300 |
Why?
|
| Uric Acid | 1 | 2007 | 32 | 0.300 |
Why?
|
| Graft Survival | 1 | 2008 | 165 | 0.300 |
Why?
|
| Graft Rejection | 1 | 2008 | 161 | 0.300 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2006 | 7 | 0.280 |
Why?
|
| Ceftazidime | 1 | 2006 | 9 | 0.280 |
Why?
|
| Phosphates | 1 | 2005 | 51 | 0.260 |
Why?
|
| Child, Preschool | 9 | 2021 | 4158 | 0.260 |
Why?
|
| Child | 9 | 2023 | 7368 | 0.250 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2005 | 97 | 0.250 |
Why?
|
| Infant | 8 | 2023 | 3829 | 0.230 |
Why?
|
| Appendix | 1 | 2003 | 28 | 0.230 |
Why?
|
| Ureter | 1 | 2003 | 38 | 0.230 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 17 | 0.220 |
Why?
|
| Renal Replacement Therapy | 1 | 2023 | 45 | 0.220 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 311 | 0.210 |
Why?
|
| Heart Transplantation | 3 | 2011 | 307 | 0.210 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2021 | 17 | 0.200 |
Why?
|
| Humans | 21 | 2023 | 54391 | 0.190 |
Why?
|
| Caregivers | 1 | 2023 | 241 | 0.190 |
Why?
|
| Cryopreservation | 1 | 2020 | 31 | 0.190 |
Why?
|
| Kidney Failure, Chronic | 3 | 2019 | 232 | 0.180 |
Why?
|
| Prospective Studies | 5 | 2022 | 2606 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 825 | 0.180 |
Why?
|
| Male | 14 | 2021 | 27347 | 0.180 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 131 | 0.170 |
Why?
|
| Catheters, Indwelling | 1 | 2019 | 68 | 0.170 |
Why?
|
| Catheter-Related Infections | 1 | 2019 | 55 | 0.170 |
Why?
|
| Adolescent | 7 | 2012 | 6900 | 0.170 |
Why?
|
| Infant, Newborn | 4 | 2023 | 2923 | 0.160 |
Why?
|
| Heart Diseases | 1 | 2021 | 239 | 0.160 |
Why?
|
| Risk Factors | 6 | 2019 | 3937 | 0.160 |
Why?
|
| Kidney | 3 | 2023 | 822 | 0.160 |
Why?
|
| Female | 13 | 2023 | 28471 | 0.150 |
Why?
|
| Cystatin C | 2 | 2021 | 9 | 0.150 |
Why?
|
| Heart Failure | 1 | 2022 | 541 | 0.140 |
Why?
|
| Quality of Life | 1 | 2023 | 924 | 0.140 |
Why?
|
| Mitochondria | 1 | 2020 | 490 | 0.140 |
Why?
|
| Hospital Mortality | 2 | 2021 | 466 | 0.130 |
Why?
|
| Treatment Outcome | 4 | 2020 | 5612 | 0.120 |
Why?
|
| Time Factors | 4 | 2019 | 3210 | 0.100 |
Why?
|
| Lipocalins | 1 | 2011 | 14 | 0.100 |
Why?
|
| Acute-Phase Proteins | 1 | 2011 | 26 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 169 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2021 | 6459 | 0.090 |
Why?
|
| Disease Progression | 1 | 2012 | 915 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2009 | 52 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2019 | 1362 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 2390 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2008 | 70 | 0.080 |
Why?
|
| Catheterization | 1 | 2008 | 108 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2008 | 154 | 0.080 |
Why?
|
| Urate Oxidase | 1 | 2007 | 6 | 0.080 |
Why?
|
| Acid-Base Equilibrium | 1 | 2007 | 9 | 0.080 |
Why?
|
| Bone Density | 1 | 2009 | 416 | 0.070 |
Why?
|
| Prognosis | 1 | 2012 | 2126 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 2009 | 226 | 0.070 |
Why?
|
| Professional-Family Relations | 1 | 2007 | 47 | 0.070 |
Why?
|
| Hospitals, Teaching | 1 | 2007 | 58 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 430 | 0.070 |
Why?
|
| Fluid Therapy | 1 | 2007 | 87 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2008 | 188 | 0.070 |
Why?
|
| Hemodialysis Solutions | 1 | 2006 | 4 | 0.070 |
Why?
|
| Arkansas | 1 | 2012 | 2100 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2009 | 444 | 0.070 |
Why?
|
| Program Development | 1 | 2007 | 198 | 0.070 |
Why?
|
| Pediatrics | 1 | 2009 | 323 | 0.070 |
Why?
|
| Phosphorus | 1 | 2005 | 30 | 0.070 |
Why?
|
| Patient-Centered Care | 1 | 2007 | 132 | 0.070 |
Why?
|
| Young Adult | 2 | 2012 | 4318 | 0.070 |
Why?
|
| Registries | 1 | 2008 | 553 | 0.060 |
Why?
|
| Creatinine | 1 | 2005 | 169 | 0.060 |
Why?
|
| Biopsy | 1 | 2007 | 692 | 0.060 |
Why?
|
| Introns | 1 | 2004 | 49 | 0.060 |
Why?
|
| Parathyroid Hormone | 1 | 2005 | 196 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2006 | 807 | 0.060 |
Why?
|
| Dialysis | 1 | 2022 | 10 | 0.060 |
Why?
|
| Urethra | 1 | 2003 | 80 | 0.060 |
Why?
|
| DNA Replication | 1 | 2004 | 152 | 0.060 |
Why?
|
| Cadaver | 1 | 2003 | 113 | 0.060 |
Why?
|
| Calcium | 1 | 2005 | 434 | 0.060 |
Why?
|
| Necrosis | 1 | 2003 | 208 | 0.050 |
Why?
|
| Oximetry | 1 | 2023 | 62 | 0.050 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2021 | 12 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2021 | 27 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 489 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2021 | 27 | 0.050 |
Why?
|
| North America | 1 | 2021 | 70 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2022 | 193 | 0.050 |
Why?
|
| Proteins | 1 | 2004 | 376 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 2021 | 88 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2005 | 541 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2022 | 486 | 0.050 |
Why?
|
| DNA | 1 | 2004 | 581 | 0.050 |
Why?
|
| Lung | 1 | 2022 | 508 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2021 | 160 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 491 | 0.040 |
Why?
|
| Adult | 2 | 2022 | 14207 | 0.040 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 302 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 1546 | 0.040 |
Why?
|
| Age Factors | 1 | 2019 | 1199 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 2639 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 1 | 2011 | 51 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 139 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 600 | 0.020 |
Why?
|
| Accreditation | 1 | 2009 | 73 | 0.020 |
Why?
|
| Problem-Based Learning | 1 | 2009 | 48 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 174 | 0.020 |
Why?
|
| Laparotomy | 1 | 2008 | 36 | 0.020 |
Why?
|
| Mortality | 1 | 2009 | 102 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 2008 | 28 | 0.020 |
Why?
|
| Morbidity | 1 | 2009 | 149 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2009 | 118 | 0.020 |
Why?
|
| Pelvis | 1 | 2008 | 77 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2009 | 379 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2009 | 232 | 0.020 |
Why?
|
| Decision Making | 1 | 2009 | 286 | 0.020 |
Why?
|
| Reoperation | 1 | 2008 | 453 | 0.020 |
Why?
|
| Curriculum | 1 | 2009 | 434 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2007 | 273 | 0.020 |
Why?
|
| TRPP Cation Channels | 1 | 2004 | 1 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 2004 | 13 | 0.020 |
Why?
|
| Students, Medical | 1 | 2007 | 178 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2004 | 43 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2004 | 92 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 225 | 0.010 |
Why?
|
| Prevalence | 1 | 2007 | 1025 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2009 | 501 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2004 | 291 | 0.010 |
Why?
|